TARPLIN, DOWNS & YOUNG, LLC

Lobbying for ELI LILLY AND COMPANY · Pharmaceutical company focused on innovation to improve global health

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Indiana · House · Senate · $60,000.00 income · posted Oct 16, 2025

Lobbying activity 3

Health Issues

IRA, non-interference, drug shortages, prescription drug access and affordability, transparency, insulin policy, drug pricing in federal programs

Medicare/Medicaid

Medicare & Medicaid payment and coverage issues, Medicare Part D, Medicare Part B, drug pricing in federal programs

Budget/Appropriations

federal budget issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.